Cargando…

Stroma Targeting Nuclear Imaging and Radiopharmaceuticals

Malignant transformation of tumor accompanies profound changes in the normal neighboring tissue, called tumor stroma. The tumor stroma provides an environment favoring local tumor growth, invasion, and metastatic spreading. Nuclear imaging (PET/SPECT) measures biochemical and physiologic functions i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shetty, Dinesh, Jeong, Jae-Min, Shim, Hyunsuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364577/ https://www.ncbi.nlm.nih.gov/pubmed/22685650 http://dx.doi.org/10.1155/2012/817682

Ejemplares similares

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
por: Everix, Liesbeth, et al.
Publicado: (2023)

Radiopharmaceutical tracers for cardiac imaging
por: Manabe, Osamu, et al.
Publicado: (2017)

CXCR4-Targeted Radiopharmaceuticals for the Imaging and Therapy of Malignant Tumors
por: Yu, Jingjing, et al.
Publicado: (2023)

Editorial: Reviews in: Radiopharmaceuticals in nuclear medicine
por: Lau, Chuen-Yen, et al.
Publicado: (2023)

(64)Cu-based Radiopharmaceuticals in Molecular Imaging
por: Zhou, Yeye, et al.
Publicado: (2019)

Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma
por: Nyakale, Nozipho, et al.
Publicado: (2023)

Eliminating the Heart from the Curcumin Molecule: Monocarbonyl Curcumin Mimics (MACs)
por: Shetty, Dinesh, et al.
Publicado: (2014)

Pharmacovigilance in radiopharmaceuticals
por: Kumar, Rishi, et al.
Publicado: (2016)

Special Issue “Targets, Tracers and Translation Novel Radiopharmaceuticals Boost Nuclear Medicine”
por: Reischl, Gerald
Publicado: (2019)

Radiopharmaceuticals for Cancer Imaging and Therapy
por: Bormans, Guy, et al.
Publicado: (2023)

A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma
por: Bolcaen, Julie, et al.
Publicado: (2021)

IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery
por: Jalilian, Amir R., et al.
Publicado: (2022)

New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease
por: Sogbein, Oyebola O., et al.
Publicado: (2014)

Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine – a review
por: Eberlein, Uta, et al.
Publicado: (2011)

Development of Folate Receptor−Targeted PET Radiopharmaceuticals for Tumor Imaging—A Bench-to-Bedside Journey
por: Boss, Silvan D., et al.
Publicado: (2020)

PET Radiopharmaceuticals for Specific Bacteria Imaging: A Systematic Review
por: Auletta, Sveva, et al.
Publicado: (2019)

Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer
por: Beauregard, Jean-Mathieu
Publicado: (2022)

NGR-Based Radiopharmaceuticals for Angiogenesis Imaging: A Preclinical Review
por: Trencsényi, György, et al.
Publicado: (2023)

Radiopharmaceuticals for PET imaging: issue A
por: Roivainen, Anne, et al.
Publicado: (2020)

Transport processes of radiopharmaceuticals and -modulators
por: Efferth, Thomas, et al.
Publicado: (2011)

Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies
por: Gutfilen, Bianca, et al.
Publicado: (2014)

Therapeutic Targeting of Hyaluronan in the Tumor Stroma
por: Kultti, Anne, et al.
Publicado: (2012)

Targeting the tumor stroma for cancer therapy
por: Xu, Maosen, et al.
Publicado: (2022)

Nanomedicine Strategies for Targeting Tumor Stroma
por: Su, Mei-Chi, et al.
Publicado: (2023)

SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic
por: Wang, Xiaobo, et al.
Publicado: (2017)

Advances in Radiopharmaceutical Sciences for Vascular Inflammation Imaging: Focus on Clinical Applications
por: Prigent, Kevin, et al.
Publicado: (2021)

Cerenkov Luminescence Tomography for In Vivo Radiopharmaceutical Imaging
por: Zhong, Jianghong, et al.
Publicado: (2011)

Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals
por: Zhou, Xu, et al.
Publicado: (2021)

Can we produce an image of bacteria with radiopharmaceuticals?
por: Signore, A., et al.
Publicado: (2008)

PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity
por: Sivapackiam, Jothilingam, et al.
Publicado: (2020)

PET Radiopharmaceuticals
por: Shahhosseini, Soraya
Publicado: (2011)

Radiopharmaceuticals for therapy
por: Knapp, F F (Russ), et al.
Publicado: (2016)

Prospective of (68)Ga-Radiopharmaceutical Development
por: Velikyan, Irina
Publicado: (2013)

Technetium Complexes and Radiopharmaceuticals with Scorpionate Ligands
por: Martini, Petra, et al.
Publicado: (2018)

Insight into the Development of PET Radiopharmaceuticals for Oncology
por: Lau, Joseph, et al.
Publicado: (2020)

Dosing Therapeutic Radiopharmaceuticals in Obese Patients
por: van Nuland, Merel, et al.
Publicado: (2022)

Radiopharmaceuticals heat anti-tumor immunity
por: Sun, Qi, et al.
Publicado: (2023)

Fundamentals of Rhenium-188 Radiopharmaceutical Chemistry
por: Kleynhans, Janke, et al.
Publicado: (2023)

Quantitative comparative analysis of amyloid PET images using three radiopharmaceuticals
por: Jeong, Young Jin, et al.
Publicado: (2023)

Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics
por: Neumaier, Felix, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tcegrn18437r8l4ng8o3nteak1